Zaite Ebola Virus

Descripción

Mapa Mental sobre Zaite Ebola Virus, creado por Alfonso Gug el 22/09/2014.
Alfonso Gug
Mapa Mental por Alfonso Gug, actualizado hace más de 1 año
Alfonso Gug
Creado por Alfonso Gug hace más de 9 años
68
0

Resumen del Recurso

Zaite Ebola Virus
  1. Background
    1. According to the WHO, the viral outbreak has led to 2240 suspected and con- firmed cases and 1229 deaths in four countries: Guinea, Liberia, Nigeria, and Sierra Leone
    2. Family: Filoviridae
      1. OTher Categories
        1. Target
          1. Humans besides Zaire
            1. Bundibugyo virus
              1. Sudan virus
                1. Taï Forest virus
                2. Non-Human Primates
                  1. Reston virus
            2. Identified in 1976 and named after the Ebola River where the first known epidemic occurred
              1. References:
                1. Zhang YF, Li DP, Jin X, Huang Z. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Sci China Life Sci, 2014, 57: 1–3, doi: 10.1007/s11427-014-4746-7
                  1. Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders in http://www.bloodjournal.org/content/91/10/3527?sso-checked=true.
                    1. Institute for Molecular Bioscience, University of Queensland, Q4072, Australia. D.Hume@imb.uq.edu.au. The MPS in http://www.ncbi.nlm.nih.gov/pubmed/16338128.
                      1. Hepatic Histology in http://www.vivo.colostate.edu/hbooks/pathphys/digestion/liver/histo_hcytes.html
                        1. Seasonal Influenza Infection Control Guidelines 2010
                          1. CDC in http://www.cdc.gov/flu/professionals/infectioncontrol/index.htm
                            1. CDPH http://www.cdph.ca.gov/programs/immunize/Documents/CDPHGuidanceFluPreventionHCS20101105.pdf
                              1. Cal/OSHA http://www.dir.ca.gov/dosh/Cal-OSHA_influenza_guidance_11-5-10.pdf
                              2. Monoclonal antibody drugs for cancer in http://www.mayoclinic.org/diseases-conditions/cancer/in-depth/monoclonal-antibody/art-20047808
                              3. Fatality Rate: 90%
                                1. the proportion of deaths within a designated population of "cases"
                                2. Infection
                                  1. Steps of infection
                                    1. Step 1
                                      1. Endothelial Cells
                                        1. ECs line vessels in every organ system and regulate the flow of nutrient substances, diverse biologically active molecules, and the blood cells themselves.
                                        2. Mononuclear Phagocytes
                                          1. Defined as a family of cells comprising bone marrow progenitors, blood monocytes and tissue macrophages. Macrophages are a major cell population in most of the tissues in the body.
                                          2. Hepatocytes
                                            1. Cells of the liver that perform an astonishing number of metabolic, endocrine and secretory functions
                                          3. Step 2
                                            1. Evade the host immune system
                                            2. Step 3
                                              1. Damages internal tissues and organs, such as blood vessels and the liver: ultimately death.
                                            3. Transmission
                                              1. Contact with Body Fluids
                                                1. Aerosol infection not proved clinically
                                                  1. Droplets: land directly on mucosal lining of nose, mouth, eyes of nearby persons or can be inhaled. Highest exposures within 3-6 feet.
                                                    1. Airborne: aerosols become smaller by evaporation; small aerosols (≤ 10 microns) remain suspended for longer periods, if inhaled travel deep into the lungs.
                                                      1. Contact: Aerosols/ secretions contaminate nearby surface. Touch surfaces can infect self or others.
                                                    2. Symptoms
                                                      1. 2 - 21 days
                                                        1. fever, muscle pain, diarrhea, vomiting
                                                        2. 21< days
                                                          1. haemorrhagic diathesis, delirium and shock
                                                      2. ZMapp
                                                        1. Efficacy of 4/5 patients
                                                          1. Experimental drug co-developed by Mapp Biophamaceutical, Inc. (San Diego, CA, USA) and Defyrus 2 Zhang. (Toronto, Canada).
                                                            1. Combination of three “humanized” monoclonal antibodies (mAbs) against the EBOV GP protein.
                                                              1. Monoclonal antibodies mimic the antibodies your body naturally produces as part of your immune system's response to germs, vaccines and other invaders.
                                                              2. Produced in plant: 3
                                                                1. MAbs produced in these glycomodified plants had mammalian-like glycans with more homogeneous glycoforms than that produced in CHO cells
                                                                  1. Glycans: large number of monosaccharides linked glycosidically
                                                                2. History
                                                                  1. Plant made antibody studies
                                                                    1. First Wave: Production of monoclonal antibodies (1989)
                                                                      1. Transgenic Technology
                                                                        1. Delivery of genes of interest into plant cells, subsequent integration of theses genes into the parental plant chromosome, and selection of stable transgenic plants.
                                                                          1. Stopped by a number of issues associated with this expression strategy, including low expression levels, long timeframes to generate transgenic plants, undesired glycosylation patterns, and concerns on spreading transgenes into the environment
                                                                        2. Second Wave: replica- tion-competent viral vectors, such as magnICON and Gemini
                                                                          1. These vectors contain elements required for viral replicon formation. Once delivered into plant cells via Agrobacterium infiltration, these vectors are able to assem- ble into replicons, which undergo automatic replication and result in a high copy number of RNA molecules encoding the desired antibody.
                                                                            1. Indoor production
                                                                              1. No spreading of recombinant genes by pollination

                                                                        Recursos multimedia adjuntos

                                                                        Mostrar resumen completo Ocultar resumen completo

                                                                        Similar

                                                                        Mis Recursos de Programación
                                                                        maya velasquez
                                                                        ¿A qué tiempo y modo corresponde?
                                                                        Remei Gomez Gracia
                                                                        SISTEMA REPRODUCTOR HUMANO
                                                                        laboratoriocienc
                                                                        Herencia Genética básica
                                                                        Catalina Ramos
                                                                        FARMACOCINETICA
                                                                        sofia collazos
                                                                        Mapa conceptual "Desarrollo Sustentable"
                                                                        Almendra Navidad
                                                                        La Capilla De Los Resurrectos.
                                                                        Karen Guerrero
                                                                        HINDUISMOA 6B_ANE
                                                                        Ane Núñez Escudero
                                                                        Insuficiencia Renal Cronica
                                                                        Angela Madroñero